TY  - GEN
AU  - Males,Sylvia
AU  - Gad,Rita Raafat
AU  - Esmat,Gamal
AU  - Abobakr,Hasan
AU  - Anwar,Mohamed
AU  - Rekacewicz,Claire
AU  - El Hoseiny,Mostafa
AU  - Zalata,Khaled
AU  - Abdel-Hamid,Mohamed
AU  - Bedossa,Pierre
AU  - Pol,Stanislas
AU  - Mohamed,Mostafa K
AU  - Fontanet,Arnaud
TI  - Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C
SN  - 1359-6535
PY  - 2007///1019
KW  - Administration, Oral
KW  - Adult
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Biomarkers
KW  - blood
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Egypt
KW  - Female
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Linear Models
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Patient Selection
KW  - Polyethylene Glycols
KW  - Proteins
KW  - metabolism
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Time Factors
KW  - Treatment Outcome
KW  - Viral Load
KW  - Virus Replication
KW  - drug effects
KW  - alpha-Fetoproteins
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
ER  -